![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Teva Czech Industries S.r.o. Opava Cz, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Teva API has over 350 products in its portfolio and is the leading international supplier of APIs.
One of their significant offerings is Bromocriptine mesilate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2006-281 - Rev 03
This Chemical Type CEP, issued on February 05, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 596 associated with this CEP further emphasizes